With consideration of PDH-P at Ser300 a significant decrease is apparent between mammary carcinoma derived cell lines MTH52C (p = 0.0263), DT14/06T (p = 0.0282) and non-treated control. This evidence concerns the gene PDP1 and breast carcinoma.